Early Development of Atherosclerotic Plaques in the Coronary Arteries after Radiotherapy for Breast Cancer (BACCARAT Study).

breast cancer contrast-enhanced CT angiography coronary atherosclerotic plaques radiotherapy

Journal

Journal of cardiovascular development and disease
ISSN: 2308-3425
Titre abrégé: J Cardiovasc Dev Dis
Pays: Switzerland
ID NLM: 101651414

Informations de publication

Date de publication:
12 Jul 2023
Historique:
received: 15 05 2023
revised: 08 07 2023
accepted: 10 07 2023
medline: 28 7 2023
pubmed: 28 7 2023
entrez: 28 7 2023
Statut: epublish

Résumé

Background-Radiotherapy (RT) for breast cancer (BC) can lead to an increased risk of coronary artery disease several years after RT. The aim of this study was to evaluate the development of overall, non-calcified and calcified atherosclerotic plaques over 2 years after BC for RT and associations with cardiac exposure. Methods-The study included 101 left- or right-sided BC patients treated with RT without chemotherapy. A coronary CT angiography was performed before and 2 years after RT. Plaque development thorough the entire coronary network was defined as an increased number of plaques. Cardiac exposure was quantified with mean doses to the heart, left ventricle, and coronary arteries. Logistic regression models were used to assess association with doses. Results-At inclusion, 37% of patients had plaques, increasing to 42% two years after RT. Overall plaque development was observed in seven patients: five with calcified plaque development and four with non-calcified plaque development. The risk of overall plaque development was significantly associated with doses to the Left Main and Circumflex coronary arteries (OR at 1 Gy = 2.32,

Identifiants

pubmed: 37504555
pii: jcdd10070299
doi: 10.3390/jcdd10070299
pmc: PMC10380516
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT02605512']

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Fédération Française de Cardiologie (FFC), Electricité de France (EDF) and the H2020 Euratom research and training program 2014-2018 under grant agreement No. 755523 in the frame of the MEDIRAD project.
ID : 755523

Références

J Cardiovasc Comput Tomogr. 2009 Nov-Dec;3 Suppl 2:S81-90
pubmed: 20129521
JACC Cardiovasc Imaging. 2009 Nov;2(11):1262-70
pubmed: 19909929
Curr Atheroscler Rep. 2017 May;19(5):22
pubmed: 28315200
JMIR Res Protoc. 2018 Oct 01;7(10):e178
pubmed: 30274965
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S77-85
pubmed: 20171522
Radiother Oncol. 2018 Jan;126(1):170-176
pubmed: 29089148
Open Heart. 2014 Aug 12;1(1):e000096
pubmed: 25332810
Radiat Oncol. 2020 Mar 30;15(1):71
pubmed: 32228654
Circ Cardiovasc Imaging. 2018 Jul;11(7):e007562
pubmed: 30012825
Circulation. 2021 Sep 21;144(12):916-929
pubmed: 34543072
Am J Med. 2009 Jan;122(1 Suppl):S3-S14
pubmed: 19110086
J Am Coll Cardiol. 2007 May 8;49(18):1860-70
pubmed: 17481445
J Clin Oncol. 2017 Apr 10;35(11):1171-1178
pubmed: 28095159
JACC Cardiovasc Imaging. 2012 Oct;5(10):990-9
pubmed: 23058065
Lancet. 2011 Nov 12;378(9804):1707-16
pubmed: 22019144
Cancers (Basel). 2022 Nov 22;14(23):
pubmed: 36497205
Circulation. 1995 Aug 1;92(3):657-71
pubmed: 7634481
Radiat Oncol. 2019 Feb 7;14(1):29
pubmed: 30732640
Eur Radiol. 2016 Sep;26(9):3223-33
pubmed: 26679184
J Am Coll Cardiol. 2009 Jun 30;54(1):49-57
pubmed: 19555840
Radiat Oncol. 2021 Nov 2;16(1):210
pubmed: 34727957
Curr Atheroscler Rep. 2019 Nov 19;21(12):50
pubmed: 31741087
Cancer. 2005 Sep 15;104(6):1129-37
pubmed: 16080176
J Am Coll Cardiol. 2015 Jul 28;66(4):337-46
pubmed: 26205589
J Am Coll Cardiol. 2017 Nov 14;70(20):2536-2551
pubmed: 29145954
Radiat Oncol. 2016 Apr 07;11:54
pubmed: 27056179
Clin Cardiol. 2018 Jan;41(1):144-150
pubmed: 29356018
J Cardiovasc Comput Tomogr. 2023 May-Jun;17(3):177-184
pubmed: 36922308
Breast. 2022 Oct;65:77-83
pubmed: 35870419
Cureus. 2021 Dec 3;13(12):e20149
pubmed: 35003981
JACC Cardiovasc Imaging. 2017 Aug;10(8):858-866
pubmed: 28797406
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Int J Radiat Oncol Biol Phys. 2022 Nov 1;114(3):409-415
pubmed: 35787926
Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1350-1359
pubmed: 33713741
Circulation. 2004 Jan 6;109(1):14-7
pubmed: 14691045
J Am Coll Cardiol. 2006 Apr 18;47(8 Suppl):C13-8
pubmed: 16631505
Nat Rev Cancer. 2011 Apr;11(4):239-53
pubmed: 21430696
N Engl J Med. 2013 Mar 14;368(11):987-98
pubmed: 23484825
J Am Coll Cardiol. 2013 Mar 12;61(10):1041-51
pubmed: 23473409

Auteurs

Manoj Kumar Honaryar (MK)

INSERM U 1018, CESP, Radiation Epidemiology Team, 94800 Villejuif, France.

Rodrigue Allodji (R)

INSERM U 1018, CESP, Radiation Epidemiology Team, 94800 Villejuif, France.
Gustave Roussy, Research Department, 94800 Villejuif, France.
University Paris-Saclay, 94800 Villejuif, France.

Gaelle Jimenez (G)

Department of Radiation Oncology (Oncorad), Clinique Pasteur, 31076 Toulouse, France.

Mathieu Lapeyre (M)

Department of Radiology, Clinique Pasteur, 31076 Toulouse, France.

Loic Panh (L)

Department of Cardiology, Clinique Pasteur, 31076 Toulouse, France.

Jeremy Camilleri (J)

Department of Radiology, Clinique Pasteur, 31076 Toulouse, France.

David Broggio (D)

Department of Dosimetry, PSE-SANTE/SDOS/LEDI, Institute for Radiation Protection and Nuclear Safety (IRSN), 92260 Fontenay-aux-Roses, France.

Jean Ferrières (J)

Department of Cardiology and INSERM UMR 1295, Rangueil University Hospital, 31400 Toulouse, France.

Florent De Vathaire (F)

INSERM U 1018, CESP, Radiation Epidemiology Team, 94800 Villejuif, France.
Gustave Roussy, Research Department, 94800 Villejuif, France.
University Paris-Saclay, 94800 Villejuif, France.

Sophie Jacob (S)

Laboratory of Epidemiology, PSE-SANTE/SESANE/LEPID, Institute for Radiation Protection and Nuclear Safety (IRSN), 92260 Fontenay-aux-Roses, France.

Classifications MeSH